To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Genzyme parent Sanofi to buy Pluromed

By Chris Reidy

 |  Globe Staff  

  March 16, 2012

Sanofi SA, the French drugmaker that bought Genzyme Corp. of Cambridge last year, said Friday that it has agreed to buy Pluromed Inc., a medical device company based in Woburn. Financial details of the agreement were not included in Sanofi’s press release. Pluromed makes a product called LeGoo, a gel used during vascular and cardiovascular surgicial procedures. According to Sanofi, LeGoo is a “breakthrough technology” that provides temporary control of blood flow while avoiding vessel trauma during such surgical procedures.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help